343 related articles for article (PubMed ID: 8794897)
1. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
Alvaro JD; Tatro JB; Quillan JM; Fogliano M; Eisenhard M; Lerner MR; Nestler EJ; Duman RS
Mol Pharmacol; 1996 Sep; 50(3):583-91. PubMed ID: 8794897
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan RA; Cone RD; Burbach JP; Gispen WH
Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
[TBL] [Abstract][Full Text] [Related]
3. Molecular and behavioral interactions between central melanocortins and cocaine.
Alvaro JD; Taylor JR; Duman RS
J Pharmacol Exp Ther; 2003 Jan; 304(1):391-9. PubMed ID: 12490616
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens.
Widnell KL; Self DW; Lane SB; Russell DS; Vaidya VA; Miserendino MJ; Rubin CS; Duman RS; Nestler EJ
J Pharmacol Exp Ther; 1996 Jan; 276(1):306-15. PubMed ID: 8558448
[TBL] [Abstract][Full Text] [Related]
5. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.
Kalange AS; Kokare DM; Singru PS; Upadhya MA; Chopde CT; Subhedar NK
Brain Res; 2007 Nov; 1181():10-20. PubMed ID: 17915196
[TBL] [Abstract][Full Text] [Related]
6. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
[TBL] [Abstract][Full Text] [Related]
7. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat.
Kishi T; Aschkenasi CJ; Lee CE; Mountjoy KG; Saper CB; Elmquist JK
J Comp Neurol; 2003 Mar; 457(3):213-35. PubMed ID: 12541307
[TBL] [Abstract][Full Text] [Related]
8. Neuroanatomical distribution of the melanocortin-4 receptors in male and female rodent brain.
Gelez H; Poirier S; Facchinetti P; Allers KA; Wayman C; Bernabé J; Alexandre L; Giuliano F
J Chem Neuroanat; 2010 Dec; 40(4):310-24. PubMed ID: 20884347
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
10. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
Nye HE; Nestler EJ
Mol Pharmacol; 1996 Apr; 49(4):636-45. PubMed ID: 8609891
[TBL] [Abstract][Full Text] [Related]
11. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
12. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
Ying Y; Lan XP; Tian YP
Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
[TBL] [Abstract][Full Text] [Related]
13. Conditioned place preference associates with the mRNA expression of diazepam binding inhibitor in brain regions of the addicted rat during withdrawal.
Liu X; Li Y; Zhou L; Chen H; Su Z; Hao W
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):47-54. PubMed ID: 15950760
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.
Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR
Brain Res; 2000 Jun; 869(1-2):203-10. PubMed ID: 10865075
[TBL] [Abstract][Full Text] [Related]
15. Morphine-induced reciprocal alterations in G alpha s and opioid peptide mRNA levels in discrete brain regions.
Basheer R; Tempel A
J Neurosci Res; 1993 Dec; 36(5):551-7. PubMed ID: 7908338
[TBL] [Abstract][Full Text] [Related]
16. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
17. Melanocortin receptor genes in the chicken--tissue distributions.
Takeuchi S; Takahashi S
Gen Comp Endocrinol; 1998 Nov; 112(2):220-31. PubMed ID: 9784305
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning, expression, and characterization of a fifth melanocortin receptor.
Gantz I; Shimoto Y; Konda Y; Miwa H; Dickinson CJ; Yamada T
Biochem Biophys Res Commun; 1994 May; 200(3):1214-20. PubMed ID: 8185570
[TBL] [Abstract][Full Text] [Related]
19. Cloning, tissue distribution, pharmacology and three-dimensional modelling of melanocortin receptors 4 and 5 in rainbow trout suggest close evolutionary relationship of these subtypes.
Haitina T; Klovins J; Andersson J; Fredriksson R; Lagerström MC; Larhammar D; Larson ET; Schiöth HB
Biochem J; 2004 Jun; 380(Pt 2):475-86. PubMed ID: 14965341
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel melanocortin4 receptor selective MSH analogues.
Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
Br J Pharmacol; 1998 May; 124(1):75-82. PubMed ID: 9630346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
